© Springer Nature Switzerland AG 2021
C. S. Foster et al. (eds.)Uveitishttps://doi.org/10.1007/978-3-030-52974-1_25

25. Acute Zonal Occult Outer Retinopathy

Marina Peskina1  
(1)
Massachusetts Eye Research and Surgery Institution, Waltham, MA, USA
 
Keywords
UveitisAcute zonal occult outer retinopathy

Overview

  • Definition
    • A retinopathy characterized by an acute onset of scotomas and photopsia, along with visual field defects and abnormal ERG that cannot be explained by funduscopic exam alone

  • Symptoms
    • Sudden onset of scotomas

    • Photopsia

    • Nyctalopia or hemeralopia

  • Laterality
    • More often unilateral on presentation, but 75% become bilateral over time (months to years)

  • Course
    • Acute onset with a self-limiting course, but recurs in one third of cases

    • Vision stabilizes over 6 months in 80% of patients
      • 70% with visual acuity 20/40 or better

    • + prognostic factors: No fundus pigmentary changes, bilateral disease, male gender

    • − prognostic factors: vitreous cells, fundus pigmentary changes, female gender

  • Age of onset
    • Mid-30s

  • Gender/Race
    • F:M = 9:1

    • Caucasian predominance

  • Systemic associations
    • 50% of patients report antecedent events
      • Viral illness within days to weeks of ocular symptoms

      • Headaches

      • Pregnancy

      • Hep B vaccination and tick bite (single cases)

    • 30% of patients have concurrent autoimmune diseases, including hypothyroidism, Hashimoto’s thyroiditis, Graves’ disease, myasthenia gravis, multiple sclerosis, insulin-dependent diabetes mellitus, CREST syndrome, Addison’s disease, Sjögren’s syndrome, and Crohn’s disease

Exam: Ocular

Anterior Segment

  • Normal, except for RAPD if one eye is more affected

Posterior Segment

  • Often appears normal initially, with very mild pigmentary changes

  • Eventual fundus depigmentation ranges from mild to severe, RP-like

  • Attenuated retinal arterioles in affected zones

  • Mild vitreous cellularity (higher grade = more diffuse outer retinal damage and worse prognosis)

  • CNV is exceedingly rare

Imaging

  • ERG
    • Despite being focal by appearance, AZOOR causes a global dysfunction of the cones and RPE. Full-field ERG findings are highly variable and there is no pathognomonic pattern

    • Reduction in amplitude and delay in the implicit time of the A and/or B wave response to photopic white light and/or 30 Hz flicker, loss of the cone component from the response to scotopic dim red light

  • VF
    • Blindspot enlargement with or without central scotomas that may correspond with mild depigmentation on fundus examination

    • May mimic central lesions

  • FAF
    • Best in delineating disease extent and monitoring for progression

    • Trizonal distribution: (1) normal FAF just outside of the boundary of lesion; (2) speckled hyper-FAF within lesion; (3) central hypo-AF indicative of RPE/choroidal atrophy

  • OCT
    • Loss of ellipsoid and outer nuclear layer in acute lesions

    • Thinning of outer and inner nuclear layers in chronic, atrophic lesions

  • FA
    • Usually normal, but may highlight mild RPE changes; peripapillary annular depigmentation; retinal arteriolar attenuation within the affected zones; slight peripapillary capillary and/or peripheral perivascular leakage

  • ICG
    • Affected zones can be hypofluorescent in both early and late phases

Differential Diagnosis

Normal Fundus

  • Retrobulbar optic neuritis

  • CNS lesions

  • Autoimmune retinopathy

  • Acute macular neuroretinopathy (AMN)

  • Acute idiopathic blindspot enlargement syndrome (AIBES)

  • Ocular migraine

Abnormal Outer Retina and RPE

  • Acute annular outer retinopathy (AAOR)

  • Serpiginous choroiditis

  • Multiple evanescent white dot syndrome (MEWDS)

  • Punctate inner choroidopathy (PIC)

  • Multifocal choroiditis and panuveitis (MCP)

  • Presumed ocular histoplasmosis syndrome (POHS)

  • Acute posterior multifocal placoid pigment epitheliopathy (APMPPE)

  • Birdshot retinochoroidopathy

  • Diffuse unilateral subacute neuroretinitis (DUSN)

  • Sectoral retinitis pigmentosa

Treatment

  • No proven treatment

  • Spontaneous stabilization or improvement of vision may occur within weeks to months

  • Systemic corticosteroids and acyclovir/valacyclovir can be trialed if vision loss is progressive

Referral/Comanagement

  • None